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Background
Mitochondrial DNA (mtDNA) is a valuable genetic bio-
marker that has been implicated as a prognostic/diagnostic
indicator for a number of diseases [1-3] as well as for
human identification where forensic biologic evidence
contains too little or no nuclear DNA, such as a hair shaft
without root or a fingernail, or where a sample from a dis-
tant maternal relative is the only possibility for comparison
[4-6]. Sanger sequencing has been the gold standard
method for mtDNA typing, but the methodology has lim-
itations with throughput, scalability, speed, and resolution
[7]. Massively parallel sequencing technology (MPS) pro-
vides platforms for more comprehensive coverage of the
genome per sample analyzed than currently is possible
with Sanger sequencing [8,9]. Moreover, a number of dif-
ferent samples, which can be distinguished by barcoding,
may be sequenced simultaneously. Two of the available
personal genome sequencers are the Ion Torrent Personal
Genome Machine (PGM™) (LifeTechnologies, San Fran-
cisco, CA) and the MiSeqTM (Illumina, Inc., San Diego,
CA). The PGM exploits non-optical sequencing on CMOS
integrated circuits by detecting small changes in pH, due
to release of H+ during addition of a nucleotide to the
growing strand within a 2 hour run time. The MiSeq uses
fluorescently tagged terminator chemistry and requires 39
hours for paired-end sequencing but has higher through-
put and an associated simpler, less labor intensive library
preparation methodology than the PGM.
With MPS potentially the mitochondrial genomes of 96
samples could be sequenced at one time. Sequencing of
the entire mitochondrial genome provides higher resolu-
tion and discrimination power than is currently possible
with only sequencing portions of the non-coding region of
the mitochondrial genome (for high information content)
or by targeted analyses (for a few SNP or deletions noted
in the coding region).
Materials and methods
DNA was extracted (QIAamp DNA Blood Mini Kit,
Qiagen, Hilden, Germany) from whole blood of volunteers
with informed consent. Whole genome mtDNA was
amplified using primers that generate two amplicons
approximately ~8.5 kb in length [9]. The general workflow
is displayed in Figure 1.
The protocol for whole mitochondrial genome
sequencing on the PGM is described on ion community
(http://ioncommunity.lifetechnologies.com/community/
applications/hid/mito/how_to). Ion Xpress™ Plus gDNA
Fragment Library Kit, OneTouch™ 200 Template Kit v2
and Ion PGM™ 200 Sequencing Kit were mainly used
for the library preparation, template preparation and
sequencing reactions, respectively. On the MiSeq, the
amplified DNA was fragmented and tagged using the
NexteraXT protocol, indexed, size selected, and pooled
for sequencing using the small amplicon targeted rese-
quencing run, which performs 251bp paired end
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illumina.com/sequencing/sequencing_instruments/miseq/
training.ilmn) analyzed with the PGM platform and Ion
314™ Chip and 48 samples were analyzed on the MiSeq.
Therefore, 23 samples were in common between the two
MPS systems. In this study, sequencing of DNA was
assessed for throughput, coverage, concordance of results
between platforms, resolution of heteroplasmy and inter-
pretation of homopolymeric stretch regions.
Results
Average coverage of the 23 samples was at least 490X in
the reactions (Figure 2):
Most variants were concordant between two different
MPS platforms and with non-coding region data gener-
ated by Sanger sequencing. High quality phylogenetic
scores (>89%) were obtained for the typing results from
all samples with Haplogrep [10] (http://haplogrep.uibk.
ac.at). While final calls were corrected manually, some
regions were problematic. Most of these problematic
areas were located at homopolymer regions due to base
position shift and heteroplasmy. In addition, read strand
bias was observed at several locations. Many of the dis-
cordant results can be corrected by software
improvements.
Conclusions
Overall, the PGM and MiSeq approaches generated
good quality sequence data rapidly with relatively high
coverage. The progress on these studies will be pre-
sented to provide insight on the near term applications
and long term potential utility of MPS for both prognos-
tic and diagnostic applications.
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Figure 1 Basic MPS workflow for mtDNA sequencing.
Figure 2 Coverage plot using MiSeq reporter displaying coverage and sequences of a selected region of two samples.
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